Cancer Therapy
Researchers develop novel anti-cancer drugs to treat solid tumors
Published in Medical Letter on the CDC and FDA, July 30th, 2006
These "small molecules" inhibit tumor growth by effectively reducing blood flow to the tumor. The results of the study appear a recent issue of the Journal of the National Cancer Institute.
"This is a novel class of drugs that increases the potential for good, effective treatment for cancer patients with tumors," said Kevin Mayo, PhD, principle investigator and professor of biochemistry, molecular biology and biophysics at the University of Minnesota Medical School.
There is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Food Poisoning
U.S. FDA issues guidance to help prevent introduction of allergens or toxins into food and feed - Newborn Screening
Use of residual dried blood spots from newborn screening programs is examined - Pneumonia Risk Factors
Severe pneumonia due to Staphylococcus aureus was linked to methicillin-resistance - Proteomics
Epstein-Barr virus nuclear antigen 2 induces Fc-receptor homolog 5 expression through CBF1 protein - Public Health
Violence against women is more likely during pregnancy than after delivery - Addiction Medicine
Assessment method affects dosage estimate in recreational ecstasy users - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
